News and Opinion - IPHA

News and Opinion

April 28, 2023

Continued long waits for new medicines in Ireland means Minister Donnelly’s new Working Group must deliver change

In 2022, it took on average 567 days from EMA authorisation to availability to patients of new innovative medicines in Ireland, among the slowest in western […]
March 15, 2023

IPHA appoints Eimear O’Leary, PhD as Director of Communications and Advocacy

The Irish Pharmaceutical Healthcare Association (IPHA) is pleased to announce the appointment of Eimear O’Leary, PhD as Director of Communications and Advocacy. Eimear previously held the […]
March 2, 2023

IPHA Conference 2023 Tánaiste’s speech

Irish Pharmaceutical Healthcare Association Annual Conference An Tánaiste, Micheál Martin TD Thank you Michael for your very warm and suspiciously complimentary introduction. And good evening ladies […]
March 2, 2023

IPHA Conference 2023 Minister Donnelly’s speech

Irish Pharmaceutical Healthcare Association (IPHA) Annual Conference, Mansion House Dublin, March 2, 2023. Good morning, I’m delighted to join you at your annual conference. I’d like […]
March 2, 2023

IPHA says Ireland should challenge proposals that would degrade investment in medicines in Europe

Annual Conference to assess innovation pipeline and supportive policies Proposals from the European Commission to weaken intellectual property rights will degrade the development and delivery of […]
February 24, 2023

IPHA welcomes Mazars Report as roadmap for faster access to life-changing new medicines

The decision by Minister for Health, Stephen Donnelly T.D. to publish the Mazars Report today has been welcomed by the Irish Pharmaceutical Healthcare Association as a […]
December 5, 2022

Almost half of people unaware what vaccines they can get for adult diseases, says Ipsos survey for IPHA

61% would follow doctor’s advice on vaccination 51% have received two or more booster Covid-19 vaccine doses 77% believe children should study science at school Almost […]
November 7, 2022

New study urges focus on competitiveness as Europe’s medicines innovators face pressure from US and Asia

IPHA urges Government to heed slide in Europe’s research and development investments and clinical trials activity as policymakers in Brussels weigh legislative changes Europe could lose […]
November 4, 2022

Policymakers should heed the shifting landscape for medicines innovation, writes Bernard Mallee

The biopharmaceutical industry is surging. But believing that the surge is permanent, or inevitable, would be a mistake. Like other industries, we are buffeted by international […]